Observational studyStem cell research & therapy2022

Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells.

Adrian Farid Elzarki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.